Upstream Bio, Inc.
UPB
$17.63
-$0.11-0.62%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.72M | 2.30M | 2.37M | 2.21M | 2.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.72M | 2.30M | 2.37M | 2.21M | 2.22M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 2.72M | 2.30M | 2.37M | 2.21M | 2.22M |
| SG&A Expenses | 23.43M | 19.99M | 17.17M | 15.24M | 13.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 124.29M | 97.06M | 80.13M | 67.98M | 58.49M |
| Operating Income | -121.57M | -94.76M | -77.76M | -65.78M | -56.27M |
| Income Before Tax | -104.47M | -79.18M | -62.81M | -53.40M | -40.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -104.47 | -79.18 | -62.81 | -53.40 | -40.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -104.47M | -79.18M | -62.81M | -53.40M | -40.51M |
| EBIT | -121.57M | -94.76M | -77.76M | -65.78M | -56.27M |
| EBITDA | -121.42M | -94.65M | -77.68M | -65.72M | -56.21M |
| EPS Basic | -8.69 | -14.44 | -18.61 | -23.16 | -18.32 |
| Normalized Basic EPS | -4.38 | -6.96 | -8.92 | -11.11 | -8.46 |
| EPS Diluted | -8.69 | -14.44 | -18.61 | -23.16 | -18.32 |
| Normalized Diluted EPS | -4.38 | -6.96 | -8.92 | -11.11 | -8.46 |
| Average Basic Shares Outstanding | 156.11M | 105.35M | 54.73M | 12.01M | 11.94M |
| Average Diluted Shares Outstanding | 156.11M | 105.35M | 54.73M | 12.01M | 11.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |